156 related articles for article (PubMed ID: 25104733)
1. Cancer signaling: when phosphorylation meets methylation.
Ying H; DePinho RA
Cell Res; 2014 Nov; 24(11):1282-3. PubMed ID: 25104733
[TBL] [Abstract][Full Text] [Related]
2. Cancer biology: Enzyme meets a surprise target.
Deuker MM; McMahon M
Nature; 2014 Jun; 510(7504):225-6. PubMed ID: 24847879
[No Abstract] [Full Text] [Related]
3. SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer.
Mazur PK; Reynoird N; Khatri P; Jansen PW; Wilkinson AW; Liu S; Barbash O; Van Aller GS; Huddleston M; Dhanak D; Tummino PJ; Kruger RG; Garcia BA; Butte AJ; Vermeulen M; Sage J; Gozani O
Nature; 2014 Jun; 510(7504):283-7. PubMed ID: 24847881
[TBL] [Abstract][Full Text] [Related]
4. Lysine methylation in cancer: SMYD3-MAP3K2 teaches us new lessons in the Ras-ERK pathway.
Colón-Bolea P; Crespo P
Bioessays; 2014 Dec; 36(12):1162-9. PubMed ID: 25382779
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of the tumor suppressor C-terminal Src kinase (Csk)-binding protein (Cbp)/PAG1 is mediated by epigenetic histone modifications via the mitogen-activated protein kinase (MAPK)/phosphatidylinositol 3-kinase (PI3K) pathway.
Suzuki K; Oneyama C; Kimura H; Tajima S; Okada M
J Biol Chem; 2011 May; 286(18):15698-706. PubMed ID: 21388951
[TBL] [Abstract][Full Text] [Related]
6. Mixed lineage kinase MLK4 is activated in colorectal cancers where it synergistically cooperates with activated RAS signaling in driving tumorigenesis.
Martini M; Russo M; Lamba S; Vitiello E; Crowley EH; Sassi F; Romanelli D; Frattini M; Marchetti A; Bardelli A
Cancer Res; 2013 Mar; 73(6):1912-21. PubMed ID: 23319808
[TBL] [Abstract][Full Text] [Related]
7. Transformation by oncogenic RAS sensitizes human colon cells to TRAIL-induced apoptosis by up-regulating death receptor 4 and death receptor 5 through a MEK-dependent pathway.
Drosopoulos KG; Roberts ML; Cermak L; Sasazuki T; Shirasawa S; Andera L; Pintzas A
J Biol Chem; 2005 Jun; 280(24):22856-67. PubMed ID: 15757891
[TBL] [Abstract][Full Text] [Related]
8. Brain cancer stem-like cell genesis from p53-deficient mouse astrocytes by oncogenic Ras.
Lee JS; Gil JE; Kim JH; Kim TK; Jin X; Oh SY; Sohn YW; Jeon HM; Park HJ; Park JW; Shin YJ; Chung YG; Lee JB; You S; Kim H
Biochem Biophys Res Commun; 2008 Jan; 365(3):496-502. PubMed ID: 18021740
[TBL] [Abstract][Full Text] [Related]
9. The SMYD3-MAP3K2 signaling axis promotes tumor aggressiveness and metastasis in prostate cancer.
Ikram S; Rege A; Negesse MY; Casanova AG; Reynoird N; Green EM
Sci Adv; 2023 Nov; 9(46):eadi5921. PubMed ID: 37976356
[TBL] [Abstract][Full Text] [Related]
10. U0126 reverses Ki-ras-mediated transformation by blocking both mitogen-activated protein kinase and p70 S6 kinase pathways.
Fukazawa H; Uehara Y
Cancer Res; 2000 Apr; 60(8):2104-7. PubMed ID: 10786668
[TBL] [Abstract][Full Text] [Related]
11. Histone methylation modifiers in cellular signaling pathways.
Alam H; Gu B; Lee MG
Cell Mol Life Sci; 2015 Dec; 72(23):4577-92. PubMed ID: 26305020
[TBL] [Abstract][Full Text] [Related]
12. Structural Basis for Substrate Preference of SMYD3, a SET Domain-containing Protein Lysine Methyltransferase.
Fu W; Liu N; Qiao Q; Wang M; Min J; Zhu B; Xu RM; Yang N
J Biol Chem; 2016 Apr; 291(17):9173-80. PubMed ID: 26929412
[TBL] [Abstract][Full Text] [Related]
13. Site-specific phosphorylation of raf in cells containing oncogenic ras-p21 is likely mediated by jun-N-terminal kinase.
Adler V; Bowne W; Michl J; Sookraj KA; Ikram K; Pestka S; Izotova L; Zenilman M; Friedman FK; Qu Y; Pincus MR
Ann Clin Lab Sci; 2008; 38(1):47-56. PubMed ID: 18316782
[TBL] [Abstract][Full Text] [Related]
14. Critical roles of non-histone protein lysine methylation in human tumorigenesis.
Hamamoto R; Saloura V; Nakamura Y
Nat Rev Cancer; 2015 Feb; 15(2):110-24. PubMed ID: 25614009
[TBL] [Abstract][Full Text] [Related]
15. Lysine methylation signaling in pancreatic cancer.
Roth GS; Casanova AG; Lemonnier N; Reynoird N
Curr Opin Oncol; 2018 Jan; 30(1):30-37. PubMed ID: 29076964
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase 4 associates with extracellular signal-regulated kinases 1 and 2, and its cellular localization is regulated by oncogenic Ras.
Zhou X; Richon VM; Wang AH; Yang XJ; Rifkind RA; Marks PA
Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14329-33. PubMed ID: 11114188
[TBL] [Abstract][Full Text] [Related]
17. Lysyl oxidase inhibits ras-mediated transformation by preventing activation of NF-kappa B.
Jeay S; Pianetti S; Kagan HM; Sonenshein GE
Mol Cell Biol; 2003 Apr; 23(7):2251-63. PubMed ID: 12640111
[TBL] [Abstract][Full Text] [Related]
18. Fine-tuning AKT kinase activity through direct lysine methylation.
Guo J; Wei W
Cell Cycle; 2019 May; 18(9):917-922. PubMed ID: 31050579
[TBL] [Abstract][Full Text] [Related]
19. Protein lysine methyltransferase SMYD3 is involved in tumorigenesis through regulation of HER2 homodimerization.
Yoshioka Y; Suzuki T; Matsuo Y; Tsurita G; Watanabe T; Dohmae N; Nakamura Y; Hamamoto R
Cancer Med; 2017 Jul; 6(7):1665-1672. PubMed ID: 28639750
[TBL] [Abstract][Full Text] [Related]
20. Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways.
Janda E; Lehmann K; Killisch I; Jechlinger M; Herzig M; Downward J; Beug H; Grünert S
J Cell Biol; 2002 Jan; 156(2):299-313. PubMed ID: 11790801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
